Dr. Lal Path Labs per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹41.48₹30.24₹58.48₹43.05₹28.82
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹41.40₹30.20₹58.40₹42.98₹28.74
₹149.65₹149.65₹259.89₹221.47₹199.80
₹172.48₹164.85₹294.43₹266.66₹241.83
—₹37.93₹68.04₹64.12₹54.68
₹27.58₹27.58₹61.59₹57.23₹49.33
—₹13.28₹24.80₹24.10₹12.35
16.816.88.48.48.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

LALPATHLAB₹1,840.00

Dr. Lal Path Labs Ltd.

· Pharma & Health
₹ CrorePeersMETROPOLISVIJAYATHYROCARENATCOPHARMNEULANDLABNHCOHANCESAILIFEMcap ₹30,838 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS28.8243.0558.4830.2441.48
Diluted EPS28.7442.9858.4030.2041.40
Book Value per Share199.80221.47259.89149.65149.65
Revenue per Share241.83266.66294.43164.85172.48
Cash Flow per Share54.6864.1268.0437.93—
Free Cash Flow per Share49.3357.2361.5927.5827.58
Dividends per Share12.3524.1024.8013.28—
Shares Outstanding (cr)8.38.48.416.816.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.